Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | DNLI |
---|---|---|
09:32 ET | 7632 | 21.705 |
09:34 ET | 1100 | 21.78 |
09:36 ET | 658 | 21.855 |
09:38 ET | 777 | 21.87 |
09:39 ET | 300 | 22 |
09:41 ET | 2200 | 22 |
09:43 ET | 1635 | 22 |
09:45 ET | 423 | 21.94 |
09:48 ET | 1300 | 22.02 |
09:50 ET | 100 | 22.02 |
09:52 ET | 803 | 21.98 |
09:54 ET | 666 | 22 |
09:56 ET | 1100 | 22 |
09:57 ET | 400 | 22.05 |
09:59 ET | 1303 | 21.925 |
10:01 ET | 4768 | 22 |
10:03 ET | 4443 | 22.13 |
10:06 ET | 2027 | 22.19 |
10:08 ET | 1608 | 22.03 |
10:10 ET | 300 | 22.03 |
10:12 ET | 1200 | 22.02 |
10:14 ET | 1739 | 22 |
10:15 ET | 800 | 21.925 |
10:17 ET | 1244 | 21.89 |
10:19 ET | 915 | 22.06 |
10:21 ET | 400 | 22.08 |
10:24 ET | 907 | 22.05 |
10:26 ET | 700 | 22.03 |
10:28 ET | 200 | 22 |
10:30 ET | 1659 | 22.025 |
10:32 ET | 600 | 22.035 |
10:33 ET | 100 | 22.01 |
10:37 ET | 200 | 22.02 |
10:39 ET | 850 | 22.0846 |
10:42 ET | 1000 | 22.16 |
10:44 ET | 200 | 22.16 |
10:46 ET | 100 | 22.05 |
10:50 ET | 200 | 22.03 |
10:51 ET | 500 | 22.04 |
10:53 ET | 927 | 21.9975 |
10:55 ET | 500 | 22.02 |
10:57 ET | 5741 | 22.095 |
11:00 ET | 700 | 22.1 |
11:02 ET | 2300 | 22.125 |
11:04 ET | 1200 | 22.07 |
11:06 ET | 500 | 22.03 |
11:08 ET | 300 | 21.975 |
11:09 ET | 604 | 21.9 |
11:11 ET | 100 | 21.9 |
11:13 ET | 1627 | 21.85 |
11:15 ET | 200 | 21.88 |
11:18 ET | 200 | 21.83 |
11:20 ET | 700 | 21.85 |
11:22 ET | 2709 | 21.83 |
11:24 ET | 500 | 21.82 |
11:26 ET | 1436 | 21.95 |
11:27 ET | 1527 | 21.875 |
11:29 ET | 1871 | 21.835 |
11:31 ET | 3262 | 21.86 |
11:33 ET | 1120 | 21.82 |
11:36 ET | 400 | 21.82 |
11:38 ET | 1958 | 21.845 |
11:40 ET | 400 | 21.84 |
11:42 ET | 600 | 21.85 |
11:44 ET | 200 | 21.855 |
11:45 ET | 700 | 21.84 |
11:47 ET | 300 | 21.86 |
11:49 ET | 300 | 21.81 |
11:51 ET | 200 | 21.79 |
11:54 ET | 433 | 21.81 |
11:56 ET | 300 | 21.775 |
11:58 ET | 937 | 21.75 |
12:00 ET | 1127 | 21.695 |
12:02 ET | 2300 | 21.66 |
12:03 ET | 2263 | 21.71 |
12:05 ET | 500 | 21.74 |
12:07 ET | 1771 | 21.795 |
12:09 ET | 900 | 21.82 |
12:12 ET | 1627 | 21.77 |
12:14 ET | 3308 | 21.77 |
12:16 ET | 3031 | 21.76 |
12:18 ET | 1635 | 21.71 |
12:20 ET | 1400 | 21.69 |
12:21 ET | 1969 | 21.68 |
12:23 ET | 1620 | 21.67 |
12:25 ET | 200 | 21.685 |
12:27 ET | 1000 | 21.67 |
12:30 ET | 300 | 21.64 |
12:32 ET | 400 | 21.64 |
12:34 ET | 800 | 21.59 |
12:36 ET | 458 | 21.58 |
12:38 ET | 1858 | 21.54 |
12:39 ET | 500 | 21.54 |
12:41 ET | 4634 | 21.53 |
12:43 ET | 3215 | 21.62 |
12:45 ET | 1747 | 21.59 |
12:48 ET | 600 | 21.57 |
12:50 ET | 2045 | 21.47 |
12:52 ET | 1600 | 21.5 |
12:54 ET | 200 | 21.49 |
12:56 ET | 445 | 21.48 |
12:57 ET | 700 | 21.46 |
12:59 ET | 1437 | 21.46 |
01:01 ET | 1376 | 21.54 |
01:03 ET | 300 | 21.52 |
01:06 ET | 500 | 21.52 |
01:08 ET | 849 | 21.54 |
01:10 ET | 967 | 21.525 |
01:12 ET | 100 | 21.545 |
01:14 ET | 800 | 21.56 |
01:15 ET | 250 | 21.55 |
01:17 ET | 820 | 21.54 |
01:19 ET | 350 | 21.51 |
01:21 ET | 600 | 21.5 |
01:24 ET | 500 | 21.47 |
01:26 ET | 300 | 21.45 |
01:28 ET | 600 | 21.4 |
01:30 ET | 300 | 21.413 |
01:33 ET | 2304 | 21.42 |
01:35 ET | 288 | 21.4 |
01:37 ET | 2300 | 21.44 |
01:39 ET | 1538 | 21.46 |
01:42 ET | 300 | 21.44 |
01:44 ET | 400 | 21.36 |
01:46 ET | 473 | 21.36 |
01:48 ET | 1419 | 21.36 |
01:50 ET | 1500 | 21.4 |
01:51 ET | 900 | 21.4 |
01:53 ET | 200 | 21.38 |
01:55 ET | 200 | 21.41 |
01:57 ET | 1900 | 21.42 |
02:00 ET | 1313 | 21.4 |
02:02 ET | 2061 | 21.445 |
02:04 ET | 400 | 21.51 |
02:06 ET | 2227 | 21.585 |
02:08 ET | 1500 | 21.63 |
02:11 ET | 100 | 21.63 |
02:13 ET | 1443 | 21.6 |
02:15 ET | 1360 | 21.57 |
02:22 ET | 100 | 21.55 |
02:24 ET | 334 | 21.55 |
02:26 ET | 1300 | 21.565 |
02:27 ET | 1700 | 21.59 |
02:29 ET | 700 | 21.65 |
02:31 ET | 662 | 21.66 |
02:33 ET | 900 | 21.64 |
02:36 ET | 900 | 21.67 |
02:38 ET | 2500 | 21.65 |
02:40 ET | 200 | 21.67 |
02:42 ET | 400 | 21.66 |
02:44 ET | 901 | 21.67 |
02:45 ET | 800 | 21.65 |
02:47 ET | 800 | 21.675 |
02:49 ET | 400 | 21.63 |
02:51 ET | 700 | 21.63 |
02:54 ET | 612 | 21.56 |
02:56 ET | 330 | 21.57 |
02:58 ET | 200 | 21.55 |
03:00 ET | 6387 | 21.66 |
03:02 ET | 1209 | 21.58 |
03:03 ET | 1827 | 21.57 |
03:05 ET | 1000 | 21.56 |
03:07 ET | 1129 | 21.54 |
03:09 ET | 1700 | 21.53 |
03:12 ET | 800 | 21.52 |
03:14 ET | 3946 | 21.51 |
03:16 ET | 3346 | 21.485 |
03:18 ET | 3100 | 21.44 |
03:20 ET | 1300 | 21.44 |
03:21 ET | 2626 | 21.43 |
03:23 ET | 1957 | 21.46 |
03:25 ET | 600 | 21.4459 |
03:27 ET | 4200 | 21.41 |
03:30 ET | 4140 | 21.41 |
03:32 ET | 7631 | 21.38 |
03:34 ET | 3804 | 21.38 |
03:36 ET | 5354 | 21.37 |
03:38 ET | 12934 | 21.41 |
03:39 ET | 34564 | 21.45 |
03:41 ET | 3597 | 21.405 |
03:43 ET | 7268 | 21.47 |
03:45 ET | 4710 | 21.54 |
03:48 ET | 2102 | 21.52 |
03:50 ET | 3584 | 21.565 |
03:52 ET | 4650 | 21.62 |
03:54 ET | 12666 | 21.695 |
03:56 ET | 25304 | 21.59 |
03:57 ET | 19295 | 21.71 |
03:59 ET | 43974 | 21.74 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Denali Therapeutics Inc | 3.1B | -22.5x | --- |
MorphoSys AG | 2.7B | -5.4x | --- |
Arrowhead Pharmaceuticals Inc | 3.2B | -6.0x | --- |
Amicus Therapeutics Inc | 2.9B | -20.0x | --- |
Genmab A/S | 16.5B | 20.9x | +22.71% |
Twist Bioscience Corp | 2.8B | -14.1x | --- |
Denali Therapeutics Inc. is a biopharmaceutical company. The Company is focused on developing a portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases and lysosomal storage disease. The Company has a portfolio of both small molecule and biotherapeutic medicines, comprising seven product candidates in clinical development across seven indications as well as preclinical therapeutic candidates. Its three late-stage development programs include tividenofusp alfa (DNL310) for mucopolysaccharidosis II (MPS II); BIIB122/DNL151 (LRRK2 inhibitor) for Parkinson’s disease; and DNL343 (eIF2B activator) for amyotrophic lateral sclerosis (ALS). SAR443820/DNL788 (RIPK1 inhibitor) is being evaluated in a Phase II study for multiple sclerosis (MS). In addition, it has a Phase I/II study of TAK-594/DNL593 for frontotemporal dementia-granulin (FTD-GRN) and a Phase I/II study of DNL126 for MPS IIIA (Sanfilippo syndrome).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.1B |
---|---|
Revenue (TTM) | $295.4M |
Shares Outstanding | 142.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.40 |
EPS | $-0.97 |
Book Value | $7.45 |
P/E Ratio | -22.5x |
Price/Sales (TTM) | 10.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -65.54% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.